Exclusive

Publication

Byline

Zydus Lifesciences beats estimates, sees high-teens growth in FY27

Mumbai, May 19 -- Zydus Lifesciences beat street estimates, with its revenue for the final quarter of 2025-26 rising 16% and net profit, adjusted for exceptional items, 15% year-on-year. The Ahmedaba... Read More


Zydus to acquire US cancer drug company Assertio for $166.4 million in all-cash deal

New Delhi, May 13 -- Zydus Lifesciences announced on Wednesday that it had signed an agreement via its subsidiary to acquire Assertio Holdings Inc. for $166.4 million in an all-cash deal. Assertio is ... Read More


Cipla bets on fast-growing biosimilars market, to steadily add products: CEO

New Delhi, May 13 -- Cipla is building a biosimilars pipeline, and aims to steadily add products over the next five years, its top executive said, as the company bets on the fast-growing market for ch... Read More